Glaxo is Europe's biggest drug maker
|
GlaxoSmithKline has bought the research institute of Croatian drug maker Pliva in a deal worth up to $50m (£28.7m).
Zagreb-based Pliva, eastern Europe's largest drug maker by sales, will get an upfront sum of $35m with possible further payments of up to $15m.
In addition, Pliva will receive royalties on certain assets should they reach the market.
Glaxo, Europe's biggest drug maker, is to take control of Pliva's intellectual property assets and employ its staff.
The deal is expected to be completed in April, subject to regulatory approval.
Home
~RS~q~RS~~RS~z~RS~33~RS~)
BBC NEWS CHANNEL
News services
E-mail this to a friend
Printable version
